Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$30.6B
sum of reported positions
Reported positions
278
Changes vs prior quarter
285
69 new · 41 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 523 measured positions in 8 quarters, the typical new or larger position finished −4.6 pts against the S&P 500 and 40% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 8.08M | $1.62B | 5.3% | |
| 3.75M | $1.34B | 4.4% | |
| 4.8M | $1.28B | 4.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $23.8B | $30.6B |
| Positions | 250 | 278 |
| Biggest line | — | NVIDIA 5% |
| 1.49M |
| $836M |
| 2.7% |
| 2.94M | $795M | 2.6% |
| 2.57M | $745M | 2.4% |
| 355K | $704M | 2.3% |
| 1.56M | $588M | 1.9% |
| 1.41M | $528M | 1.7% |
| 1.92M | $517M | 1.7% |
| 417K | $500M | 1.6% |
| 1.74M | $442M | 1.4% |
| 929K | $413M | 1.3% |
| 677K | $382M | 1.2% |
| 1.05M | $353M | 1.2% |
| 241K | $283M | 0.9% |
| 228K | $263M | 0.9% |
| 762K | $262M | 0.9% |
| 6.15M | $261M | 0.9% |
| 1.7M | $248M | 0.8% |
| 2.21M | $245M | 0.8% |
| 6M | $245M | 0.8% |
| 511K | $244M | 0.8% |
| 1.62M | $244M | 0.8% |
| 331K | $239M | 0.8% |
Pattern Group (PTRN)
1.17M → 1.66M shares (+41%)
Applied Digital (APLD)
542K → 1.04M shares (+92%)
Freeport-McMoRan (FCX)
544K → 613K shares (+13%)
Rigetti Computing (RGTI)
1.9M → 1.95M shares (+3%)
Uranium Energy (UEC)
1.57M → 2.8M shares (+79%)
Alphabet (GOOGL)
50K → 58K shares (+14%)
Walmart (WMT)
72K → 88K shares (+24%)
Thermo Fisher Scientific (TMO)
13K → 14K shares (+6%)
Merck (MRK)
43K → 53K shares (+24%)
Pfizer (PFE)
134K → 162K shares (+21%)
VANGUARD INDEX FDS
2,443 → 23K shares (+848%)
Intuitive Surgical (ISRG)
4,036 → 4,572 shares (+13%)
Boston Scientific (BSX)
5,965 → 34K shares (+476%)
UnitedHealth (UNH)
2,767 → 3,377 shares (+22%)
Vertex Pharmaceuticals (VRTX)
864 → 2,189 shares (+153%)
Ionis Pharmaceuticals (IONS)
3,502 → 4,233 shares (+21%)
